Cargando…
Recent Progress of Novel Nanotechnology Challenging the Multidrug Resistance of Cancer
Multidrug resistance (MDR) of tumors is one of the clinical direct reasons for chemotherapy failure. MDR directly leads to tumor recurrence and metastasis, with extremely grievous mortality. Engineering a novel nano-delivery system for the treatment of MDR tumors has become an important part of nano...
Autores principales: | Zhang, Chengyuan, Zhou, Xuemei, Zhang, Hanyi, Han, Xuanliang, Li, Baijun, Yang, Ran, Zhou, Xing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883114/ https://www.ncbi.nlm.nih.gov/pubmed/35237155 http://dx.doi.org/10.3389/fphar.2022.776895 |
Ejemplares similares
-
Recent nanotechnology advancements to treat multidrug-resistance pancreatic cancer: Pre-clinical and clinical overview
por: Alshememry, Abdullah K., et al.
Publicado: (2022) -
Research Progress on Natural Diterpenoids in Reversing Multidrug Resistance
por: Deng, Zhuo-fen, et al.
Publicado: (2022) -
Recent Advances in Nanotechnology for Dendritic Cell-Based Immunotherapy
por: Qian, Chen, et al.
Publicado: (2020) -
Challenges and Opportunities of Nanotechnology as Delivery Platform for Tocotrienols in Cancer Therapy
por: Maniam, Geetha, et al.
Publicado: (2018) -
Nanotechnology-Based Diagnostic and Therapeutic Strategies for Neuroblastoma
por: Yan, Hui, et al.
Publicado: (2022)